If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
14.625    -0.125 (-0.85%)
Bid:
14.25
Ask:
15.00
Spread: 0.75 (5.263%)
Market Cap: £71.05m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Disposal

12 Nov 2009 09:48

RNS Number : 4027C
China Real Estate Opportunities PLC
12 November 2009
 



 

China Real Estate Opportunities plc

Disposal of interest in RREEF CCT

China Real Estate Opportunities plc (the "Company") (AIM: CREO) announces that it has disposed of a further 4,603,000 units (0.99%) in RREEF China Commercial Trust ("RREEF CCT"), a Hong Kong listed Real Estate Investment Trust, at an average price of HKD2.99 per unit, through on-market sales. Following these sales, the Company has a holding of 27,816,000 units (5.99%) in RREEF CCT.

Contact:

China Real Estate Opportunities plc

Ray Horney, Chairman

Tel: + 44 (0) 1273 775 225 

Sarah Moriarty, Investor Relations

Tel: + 353 1 618 9455

Matrix Corporate Capital LLP

Paul Fincham

Tel: + 44 (0) 20 3206 7000

Davy

Des Carville

Tel: + 353 1 679 6363

Citigate Dewe Rogerson Limited

Tom Baldock

Tel: + 44 (0) 20 7638 9571

Murray Consultants 

Ed Micheau

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISGCBDBRSBGGCD
Date   Source Headline
22nd Jan 200712:00 pmRNSFinal Results
22nd Jan 200711:50 amRNSPosting of Circular
14th Dec 20069:17 amRNSProposed Acquisition
8th Dec 200610:00 amRNSSuspension of Shares
8th Dec 200610:00 amRNSSuspension- China Real Estate
27th Sep 20069:30 amRNSInterim Results
25th Sep 200611:21 amRNSRe: Grant of share options
4th Jan 200611:02 amRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.